The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Deniz Can,Guven ^[1] ; Enes,Erul ^[2] ; Taha Koray,Sahin ^[2] ; Omer,Dizdar ^[1] ; Suayib,Yalcin ^[1] ; Ibrahim Halil,Sahin ^[3]

作者单位： Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06100, Turkey. ^[1] Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, 06100, Turkey. ^[2] Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. ^[3]

关键词 HBV HCV combination hepatocellular carcinoma immune checkpoint inhibitor immunotherapy meta-analysis survival

DOI 10.2217/fon-2022-0642

PMID 36533987

发布时间 2024-02-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Future oncology (London, England)

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Future oncology (London, England)

相似文献

Future oncology (London, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Future oncology (London, England)

相似文献

Future oncology (London, England)

相关期刊

检索历史清除